Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia

Oral Diseases

Volumn 20, Issue 1, 2014, Pages 1-5

  Scully, C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Carcinoma; Erythroplakia; Leukoplakia; Lichen; Lichenoid; Neoplasia; Oral; Potentially malignant lesions

Indexed keywords

ARTICLE; CANDIDIASIS; CHEILITIS; ERYTHROPLASIA; HUMAN; LEUKOPLAKIA; LICHENOID; MOUTH SQUAMOUS CELL CARCINOMA; NEOPLASM; ORAL MUCOSAL DISEASE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RISK FACTOR; TUMOR SUPPRESSOR GENE; CELL TRANSFORMATION; DISEASE COURSE; MOUTH DISEASE; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PROGNOSIS;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; MOUTH DISEASES; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS;

EID: 84890063178     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12208     Document Type: Article

References (52)

1. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA (1995). Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80: 188-191.
2. Angadi PV, Rekha KP (2011). Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians. Oral Maxillofac Surg 15: 15-19.
3. Arduino P, Bagan J, El-Naggar A, Carrozzo M (2013). Urban legends series: oral leukoplakia. Oral Dis 19: 642-659.
4. Braakhuis BJ, Leemans CR, Brakenhoff RH (2004). A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33: 317-322.
5. Bradley G, Odell EW, Raphael S et al (2010). Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Br J Cancer 103: 1432-1442.
6. Bremmer JF, Brakenhoff RH, Broeckaert MA et al (2011). Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol 47: 956-960.
7. Brennan M, Migliorati CA, Lockhart PB et al (2007). Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl 1): S19.e1-S19.e12.
8. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D (2000). Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6: 347-352.
9. Chiesa F, Sala L, Costa L et al (1986). Excision of oral leukoplakias by CO2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori 30: 307-312.
10. Einhorn J, Wersall J (1967). Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 20: 2189-2193.
11. Fischer DJ, Epstein JB, Morton TH, Schwartz SM (2004). Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. J Oral Pathol Med 33: 65-70.
12. Georgakopoulou EA, Troupis TG, Troupis G, Gorgoulis VG (2011). Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature. J BUON 16: 613-616.
13. Georgakopoulou EA, Achtari MD, Achtaris M, Foukas PG, Kotsinas A (2012). Oral lichen planus as a preneoplastic inflammatory model. J Biomed Biotechnol 2012: 759626. doi:10.1155/2012/759626. Epub May 17.
14. Giaretti W, Maffei M, Pentenero M et al (2012a). Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell Oncol (Dordr) 35: 43-52.
15. Giaretti W, Pentenero M, Gandolfo S, Castagnola P (2012b). Chromosomal instability, aneuploidy and routine high-resolution DNA content analysis in oral cancer risk evaluation. Future Oncol 8: 1257-1271.
16. Giaretti W, Monteghirfo S, Pentenero M, Gandolfo S, Malacarne D, Castagnola P (2013). Chromosomal instability, DNA index, dysplasia, and subsite in oral premalignancy as intermediate endpoints of risk of cancer. Cancer Epidemiol Biomarkers Prev 22: 1133-1141.
17. Hardy H, Persac S, Péron JM (2010). Upper aerodigestive tract erythroplakia. Rev Stomatol Chir Maxillofac 111: 213-215.
18. Holmstrup P (2009). Can we prevent malignancy by treating premalignant lesions? Oral Oncol 45: 549-550.
19. Holmstrup P, Vedtofte P, Reibel J, Stoltze K (2006). Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42: 461-474.
20. Holmstrup P, Vedtofte P, Reibel J, Stoltze K (2007). Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 36: 262-266.
21. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM (2007). Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 36: 25-29.
22. Jégu J, Binder-Foucard F, Borel C, Velten M (2013). Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol 49: 9-14.
23. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E (1995). Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24: 198-200.
24. Kujan O, Khattab A, Oliver RJ, Roberts SA, Thakker N, Sloan P (2006). Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol 43: 224-231.
25. Lee JJ, Hong WK, Hotelman WN, Mao L et al (2000). Predicting cancer development in oral leukoplakia: ten years of translation research. Clin Cancer Res 7: 1702-1710.
26. Lingen MW (2010). Screening for oral premalignancy and cancer: what platform and which biomarkers. Cancer Prev Res (Phila) 3: 1056-1059.
27. Lodi G, Porter S (2008). Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med 37: 63-69.
28. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A (2006). Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 18: CD001829.
29. Manchanda A, Shetty DC (2012). Reproducibility of grading systems in oral epithelial dysplasia. Med Oral Patol Oral Cir Bucal 17: e935-e942.
30. Mithani SK, Mylar WK, Grumbine FL, Smith IM, Califano JA (2007). Molecular genetics of premalignant oral lesions. Oral Dis 13: 126-133.
31. Nankivell P, Williams H, Matthews P et al (2013). The binary oral dysplasia grading system: validity testing and suggested improvement. Oral Surg Oral Med Oral Pathol Oral Radiol 115: 87-94.
32. Napier S, Speight P (2008). Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 37: 1-10.
33. Petti S, Scully C (2006). Association between different alcoholic beverages and leukoplakia among non- to moderate-drinking adults: a matched case-control study. Eur J Cancer 42: 521-527.
34. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S (2009). Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 38: 737-752.
35. Reibel J, Holmstrup P (2010). Premalignant disorders and cancer of the oral mucosa. Ugeskr Laeger 172: 3040-3042.
36. Rosin MP, Lam WL, Poh C et al (2002). 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 62: 6447-6450.
37. Röth GJ, Schirner E, Hornstein OP, Simon M Jr (1984). Precancerous conditions and carcinomas of the lower lip. Coincidence with leukoplakia and carcinomas of the oral cavity and larynx. Dtsch Med Wochenschr 109: 1229-1231.
38. Saini R, Poh C (2013). Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders. Oral Dis 19: 440-451.
39. Scully C, Sudbo J, Speight PM (2003). Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 32: 251-256.
40. Slaughter DP, Southwick HW, Smejkal W (1953). Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968.
41. Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H (2009). Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 45: 647-653.
42. Sperandio M, Brown AL, Lock C et al (2013). Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res (Phila) 6: 822-831.
43. Sreenivasan V (2013). The malignant potential of oral lichen planus-confusion galore. Oral Surg Oral Med Oral Pathol. Oral Radiol 115: 415.
44. Thomson PJ (2002). Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 31: 262-266.
45. Torres-Rendon A, Stewart R, Craig GT, Wells M, Speight PM (2009). DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol 45: 468-473.
46. Villa A, Villa C, Abati S (2011). Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J 56: 253-256.
47. van der Waal I (2009). Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45: 317-323.
48. van der Waal I (2010). Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 46: 423-425.
49. Wang LH, Ting SC, Chen CH et al (2010). Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population. J Oral Pathol Med 39: 155-161.
50. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E (2008). Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37: 127-133.
51. Zhang L, Rosin MP (2001). Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 30: 513-520.
52. Zhang L, Poh CF, Rosin MP et al (2012). Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila) 5: 1081-1089.